Mice with late-life systemic lupus erythematosus (SLE) backgrounds develop early, severe disease when subjected to various accelerating factors. Similar immunostimulation of normal mice leads to relatively innocuous autoimmune responses (1-4).
In each group, autopsies were done on mice that appeared moribund (not necessarily due to GN), or at 12 or 17 mo of age. The degree of lymphoproliferation and severity of histopathology in each group represent average values obtained with 15 mice.
Results
As indicated in Table I , immunostimulation by lpr accelerated the latent disease (giomerulonephritis [GN] and arthritis) of SLE-prone MRL/n mice (50% mortality reduced from 17 to 5.5 mo). In contrast, lpr had much less diseaseinducing effect on C567BL/6 and C3H/HeJ mice. Even at 12 mo, these mice had only mild GN and no arthritis, and did not die from kidney failure. Chronic immunostimulation by LPS accelerated the latent autoimmunity and GN (though not the arthritis) of MRL/n mice (50% mortality at 6.5 too), but induced much milder SLE in LPS-responding normal mice (B6), and none in LPS-nonresponding normal mice (C3H/HeJ). When subjected to simultaneous lpr and LPS immunostimulation, normal mice (B6) developed early-onset, fatal SLE (50% GN-associated mortality at 7.5 mo).
The total lymphoid mass (at 5 mo), reflecting the degree of lpr-induced lymphoid hyperplasia, was highest in MRL-lpr, followed closely by C3H-lpr mice. B6-lpr mice had less lymphoproliferation, although proliferation increases to comparable levels with age or simultaneous LPS treatment. LPS-induced lymphoproliferation was manifested by weight increases in the spleen, rather than in lymph nodes.
Each of lpr and LPS increased the total IgG in all three strains, except in the case of C3H/HeJ injected with LPS (Table II) . In SLE-prone MRL/n mice, lpr induced the highest increases of IgG, particularly IgG1 and IgG2a, while LPS induced smaller increases, predominantly in IgG2b. In the two normal strains, lpr induced a smaller IgG increase, but the increase was in the same IgG subclasses as in MRL. In the LPS responder, B6, the LPS-associated increase was predominantly in the IgG2b subclass. With superimposed LPS stimulation, B6-lpr mice attained IgG levels nearly equivalent to MRL-lpr mice, but the predominant IgG isotype was IgG2b.
In MRL mice, lpr markedly increased the total CIC and specifically increased (Table II) . In the other two strains, each immunostimulator raised the levels of these two complexes somewhat above unmanipulated controls. In contrast, B6-lpr mice subjected to prolonged LPS stimulation showed significant CIC increases.
Anti-single-stranded DNA autoantibodies in all three lpr strains were increased over non-lpr controls, the highest in lupus-background mice. LPS increased these autoantibodies in the two LPS-responder strains, but not in nonresponder C3H/HeJ. In MRL-lpr mice, most antibodies (70%) were IgG1 and IgG2a, while they were mostly IgM in young, normal-background lpr and LPS-treated non-lpr mice. Analysis of 5-10 sera from young and old lpr mice revealed that the switch from IgM to IgG anti-single-stranded DNA autoantibodies occurred in 4-5-mo-old MRL-lpr mice, but was delayed to 10-12 mo of age in normal-background Ipr mice (data not shown).
Total IgM and IgM rheumatoid factors (RF) increased in MRL-Ipr homozygous or normal genetic background mice, and in LPS-responding mice. The Iprinduced IgM RF were higher in B6-1pr and C3H-lpr than in MRL-lpr mice (Table III) . MRL-lpr RF represented 23% of the total IgM; B6-lpr and C3H-lpr RF comprised 62 and 59% of their total IgM, respectively-. Interestingly, chronic LPS treatment of B6-1pr mice reduced, rather than increased, IgM RF. MRLlpr IgM RF exhibited higher reactivity with the IgG2a substrate, whereas B6-lpr and C3H-lpr IgM RF had higher anti-IgG1 activity. In the two responder strains, LPS induced polyclonal IgM RF that reacted primarily with IgG 1.
Discussion
The main findings of this study are: (a) Genetic background influences the specificities and isotypes of autoimmune responses and the distribution and In contrast to lupus-prone mice, introduction of lpr or LPS into normalbackground mice failed to cause significant immunopathology. This was despite the induction of autoantibodies, as previously reported (4, 11) . Higher amounts of autoantibodies and IC, and the earlier switch of autoantibodies from IgM to IgG may account for the severe immunopathology in lupus-prone, but not in normal mice. It is likely that activated B cells in lupus-background mice (7, 12) respond better to proliferation and differentiation factors secreted by the lpr- The novel finding is that two simultaneously administered immunostimulators can overcome the resistance shown by B6 mice to induction of significant autoimmune disease by either stimulator alone. LPS-activated B6-lpr B cells may have an increased ability to receive and respond to lpr-induced antigen-nonspecific differentiation factors, which allows increased polyclonal Ig and autoantibody production above threshold levels. In lupus-background (MRL/n) mice, the apparently increased numbers of spontaneously activated B cells (9, 12) allows them to respond to lpr stimulation alone to attain their pathogenic potentials.
Previous studies (13, 14) indicate that in vivo and in vitro lymphocytes from normal mice secrete autoantibodies spontaneously or after mitogenic stimulation. Idiotypes expressed on autoantibodies from lupus mice are also expressed in normal mice (15) and, conversely, idiotypes of autoantibodies from normal mice can be found in lupus mice (16) . Despite this, the idiotype similarities may be only partial, or caused by parallel sets of antibodies without specificities for autoantigens (15) , and do not necessarily include pathogenic idiotypes. Our findings indicate that most of the autoantibody variable region gene repertoire is represented in normal-background mice, but needs an appropriate stimulus or combinations of stimuli to be fully expressed. These findings complement recent protein sequencing (17) and molecular cloning (18, 19) experiments which suggest that the structural genetic elements of autoantibodies from lupus mice are closely related to those encoding antibodies to exogenous antigens in normal mice.
Summary
Either of two immunostimulating factors (lpr, lipopolysaccharide) enhanced the pathogenic autoimmune responses of MRL/n mice, but the serologic and immunopathologic characteristics differed. In contrast, either factor, acting alone, caused minimal immunopathology in normal mice, despite autoantibody induction. Combined immunostimulation, however, caused fatal glomerulonephritis in normal-background C57BL/6 mice. These results show the profound influence of the background genome on the effects of immunostimulating agents, and show that resistance to autoimmune disease in immunologically normal mice is not absolute.
